Cure8 research brief
This study shows that sodium butyrate, a metabolite produced by gut bacteria, changed brain imaging measures and reduced inflammation in mice with experimental IBD, supporting the idea that gut-derived compounds can affect the brain via the gut–brain axis.
Researchers in gut–brain axis, microbiome and neuroimaging; clinicians interested in basic-science links between IBD and brain changes
Researchers used a mouse model of IBD to study whether sodium butyrate (NaB), a gut microbial metabolite, affects brain structure and function through the gut–brain axis.
Mice were scanned with high-field MRI (DTI, T2-weighted imaging, and fMRI) to compare white matter integrity, grey matter nucleus volumes, and neural activity across healthy, IBD, and IBD+NaB groups.
The study reports that NaB reduced inflammation in IBD mice and produced measurable differences in MRI metrics: altered mean diffusivity in a cerebellar white matter tract, changes in volumes of certain brain nuclei (including the left caudoputamen), and group differences in regional neural activity and local activity coherence (examples include thalamic, hippocampal CA3, and nucleus accumbens regions).
These findings are from an animal experimental study using multimodal imaging and do not demonstrate effects in people with IBD. The results suggest NaB can influence brain measures in mice with experimental IBD, supporting a gut–brain axis link worth further study.
Animal imaging and inflammation outcomes suggest a mechanistic link but do not establish safety or clinical benefit in people. The report is a basic-science journal article; further work including human studies is required.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: Tianjin Medical University Integrated Traditional Chinese and Western Medicine Research Fund - 2024XKZXY08; China Postdoctoral Science Foundation - 2021M702461; Tianjin Union Medical Center Project - 2020YJ023; National Natural Science Foundation of China - 12174203
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This preclinical study suggests a plant-derived polysaccharide (THP) can repair the gut vascular barrier and reduce inflammation in experimental colitis via the S1P/S1PR2 pathway, pointing to a novel potential target for...
The review outlines new research tools for investigating whether mycobacteria contribute to Crohn’s disease and how the microbiome might influence infection and intestinal inflammation, which could eventually inform...
Researchers are exploring ways to deliver drugs selectively to inflamed gut tissue in IBD to boost local effectiveness and reduce systemic side effects. Progress in smart nanoparticles and hydrogels could eventually...
